指南与共识技术与安全介入CTDSA

碘对比剂超敏反应的管理与预防:美国放射学会与美国过敏、哮喘和免疫学会的共识声明

Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement From the American College of Radiology and the AAAAI.
指南 / 共识 · J Allergy Clin Immunol Pract · 2025-03-10

美国放射学会与美国过敏、哮喘和免疫学会组成联合专家组,评估科学证据,就静脉碘对比剂超敏反应的管理、预防及预用药达成共识推荐,以调和两学会既往建议的不一致并规范患者照护。

要点

  • 两学会既往建议存在分歧:放射学会手册推荐预用药预防重复超敏反应,而2020年过敏反应实践参数更新建议不常规使用糖皮质激素和/或抗组胺药预防。
  • 联合专家组评估证据强度,并权衡复发反应风险与预用药及产品规避的风险后形成共识推荐。
  • 共识推荐获两学会共同认可,旨在改善和规范对发生或曾有碘对比剂反应患者的照护。

核心结论

  • 专家组基于证据强度并权衡复发反应风险与预用药及产品规避风险,形成获两学会认可的共识推荐,以改善和规范碘对比剂反应患者的照护。

研究设计与样本

  • 由放射学专家(兼美国放射学会药物与对比剂媒体委员会成员)与过敏/免疫学专家(含美国过敏、哮喘和免疫学会药物、生物制剂和乳胶不良反应委员会成员)组成联合专家组,评估科学证据后制定共识推荐。

诊断标准与关键数值

  • 美国放射学会对比剂手册推荐预用药以预防碘对比剂重复超敏反应,而2020年过敏反应实践参数更新建议不常规给予糖皮质激素和/或抗组胺药以预防既往碘对比剂超敏反应患者的过敏反应。

临床应用与阅片要点

  • 专家组共识推荐获美国放射学会与美国过敏、哮喘和免疫学会共同认可,用于指导既往有碘对比剂反应患者的准备、规划和潜在预用药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Intravenous iodinated contrast media (ICM) is widely used in the United States, and it is imperative to provide guidance on the management of adverse reactions to ICM as well as the preparation, planning, and potential premedication for patients with previous reactions. Currently there is a discordance between the American College of Radiology Contrast Manual, which recommends premedication to prevent repeat hypersensitivity reactions to ICM, and the Anaphylaxis 2020 Practice Parameters Update, which recommends against routine administration of glucocorticoids and/or antihistamines to prevent anaphylaxis with prior ICM hypersensitivity reactions. A task force of experts from radiology who are also members of the American College of Radiology Committee on Drugs and Contrast Media and expert allergists/immunologists including members of the Adverse Reactions to Drugs, Biologics and Latex Committee of American Academy of Allergy, Asthma & Immunology evaluated the scientific evidence to develop consensus recommendations that are endorsed by both organizations. The task force took into account the strength of evidence and balanced the potential risks of recurrent reactions with those of premedication and product avoidance when making these recommendations to improve and standardize the care of patients who experience or have a history of reaction to ICM.

来源:J Allergy Clin Immunol Pract,查看原文。版权归原作者所有。

引用

  1. Wang C, Ramsey A, Lang D, et al. Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement From the American College of Radiology and the AAAAI. J Allergy Clin Immunol Pract. 2025. PMID: 40332064. doi:10.1016/j.jaip.2025.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。